Zolimidine
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name 2-[4-(Methanesulfonyl)phenyl]imidazo[1,2-a]pyridine | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider |
|
ECHA InfoCard | 100.013.589 ![]() |
KEGG |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C14H12N2O2S |
Molar mass | 272.32 g/mol |
Density | 1.31 g/cm3 |
Pharmacology | |
A02BX10 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). ![]() ![]() ![]() Infobox references |
Chemical compound
Zolimidine (zoliridine, brand name Solimidin) is a gastroprotective[1] drug previously used for peptic ulcer[2] and gastroesophageal reflux disease.[3]
See also
- Imidazopyridine
References
- ^ Parisio, C; Clementi, F (November 1976). "Surface Alterations Induced by Stress in Gastric Mucosa: Protective Effect of Zolimidine. A Transmission and Scanning Electron Microscope Investigation". Laboratory Investigation. 35 (5): 484–95. PMID 136548.
- ^ Belohlavek, D; Malfertheiner, P (1979). "The Effect of Zolimidine, Imidazopyridine-derivate, on the Duodenal Ulcer Healing". Scandinavian Journal of Gastroenterology. Supplement. 54: 44. PMID 161649.
- ^ Materia, A; Basso, N; Bagarani, M; Basoli, A; Speranza, V (30 April 1981). "Treatment of Alkaline Reflux Gastritis with Zolimidine. Controlled Study". La Clinica Terapeutica. 97 (2): 183–91. PMID 6453678.
- v
- t
- e
analogues ("-prost-")
("-prazole")
acid blockers ("-prazan")
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
- See also: Helicobacter pylori eradication protocols
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e